These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 738325)

  • 21. [Acute adult leukemia. Therapeutic options including supportive measures].
    Jehn U; Wilmanns W
    MMW Munch Med Wochenschr; 1980 Apr; 122(14):494-8. PubMed ID: 6769025
    [No Abstract]   [Full Text] [Related]  

  • 22. Biphenotypic acute leukaemia: a case series.
    Aribi A; Bueso-Ramos C; Estey E; Estrov Z; O'Brien S; Giles F; Faderl S; Thomas D; Kebriaei P; Garcia-Manero G; Pierce S; Cortes J; Kantarjian H; Ravandi F
    Br J Haematol; 2007 Jul; 138(2):213-6. PubMed ID: 17593028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Phase II study of NK 171 (etoposide) on malignant lymphomas and acute leukemia. A cooperative study group on NK 171 in hematological malignancies].
    Kimura K; Yamada K; Yoshida T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):496-501. PubMed ID: 3954373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213.
    Rivera G; Avery T; Roberts DW
    Eur J Cancer (1965); 1975 Sep; 11(9):639-47. PubMed ID: 1220978
    [No Abstract]   [Full Text] [Related]  

  • 25. Remission induction in acute myeloid leukaemia with oral etoposide.
    Evans JP; Prentice HG
    Lancet; 1982 Dec; 2(8311):1345-6. PubMed ID: 6128632
    [No Abstract]   [Full Text] [Related]  

  • 26. Adverse effects of aneuploidy on the outcome of remission induction therapy for acute nonlymphocytic leukaemia: analysis of types of treatment failure.
    Preisler HD; Reese PA; Marinello MJ; Pothier L
    Br J Haematol; 1983 Mar; 53(3):459-66. PubMed ID: 6824587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adriamycin-cytosine arabinoside therapy for adult acute myelocytic leukemia.
    Preisler HD; Bjornsson S; Henderson ES
    Cancer Treat Rep; 1977; 61(1):89-92. PubMed ID: 324625
    [No Abstract]   [Full Text] [Related]  

  • 28. [Results of combined chemotherapy in treatment-resistant leukaemia of adults (author's transl)].
    Bruntsch U; Osieka R; GAllmeier WM; Seeber S; Schmidt CG
    Dtsch Med Wochenschr; 1975 Nov; 100(48):2478-82. PubMed ID: 1059536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination chemotherapy of adult acute nonlymphoblastic leukemia.
    Levi JA; Vincent PC; Gunz FW
    Ann Intern Med; 1972 Mar; 76(3):397-403. PubMed ID: 4502024
    [No Abstract]   [Full Text] [Related]  

  • 30. Induction of remission in hepatocellular carcinoma. A comparison of VP 16 with adriamycin.
    Melia WM; Johnson PJ; Williams R
    Cancer; 1983 Jan; 51(2):206-10. PubMed ID: 6295596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 'pre-induction course' with non-cross-reacting cytostatic drugs for rapid tumour load reduction improves outcome in adult acute lymphoblastic leukaemia.
    Daenen S; van Imhoff GW; de Wolf JT; Vellenga E; van den Berg-de Ruiter E; Kluin-Nelemans HC
    Br J Haematol; 2007 Jul; 138(2):275-7. PubMed ID: 17593034
    [No Abstract]   [Full Text] [Related]  

  • 32. Letter: Adriamycin in acute leukaemia.
    Smith IE; McElwain TJ
    Lancet; 1974 Jul; 2(7873):161. PubMed ID: 4135524
    [No Abstract]   [Full Text] [Related]  

  • 33. [Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
    Esumi N; Todo S; Arakawa S; Imashuku S
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):951-8. PubMed ID: 3963859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remission induction of adult acute leukemia with combination chemotherapy.
    Rodriguez V; Gutterman JU; Scotti MJ
    Clin Pharmacol Ther; 1971; 12(6):963-71. PubMed ID: 5289713
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of acute nonlymphoblastic leukemia in children with a multiple-drug protocol.
    Haghbin M; Murphy ML; Tan CT
    Cancer; 1977 Oct; 40(4):1417-21. PubMed ID: 907961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adriamycin and VP16-213 combination treatment for breast cancer previously treated by the CMF regimen.
    Perez Manga G; Madrigal Alonso P; Alburquerque Carbuccia H
    Cancer Chemother Pharmacol; 1982; 7(2-3):231-3. PubMed ID: 6896298
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical and cell kinetic studies of the effects of the epipodophyllotoxin VP16-213 during therapy of refractory acute nonlymphocytic leukemia.
    Look AT; Dahl GV; Rivera G; Mauer AM
    Cancer Chemother Pharmacol; 1982; 7(2-3):161-7. PubMed ID: 6177437
    [No Abstract]   [Full Text] [Related]  

  • 38. Etoposide in combination with cytarabine, doxorubicin, and 6-thioguanine for treatment of acute nonlymphoblastic leukemia in a protocol adjusted for age.
    Bern MM; Wallach SR; Arkin CF; Lokich JJ; Huberman MS; Anderson NR; Corkery JC; Paul SD; Phillips DF; Sonneborn HA
    Cancer Treat Rep; 1987 Feb; 71(2):201-3. PubMed ID: 3802115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of VP-16 and the combination of adriamycin and vincristine in advanced breast cancer.
    Eagan RT; Ahmann DL; Bisel HF
    Oncology; 1976; 33(3):146-8. PubMed ID: 1012648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current concepts in acute leukemia.
    McCredie KB
    Postgrad Med; 1977 Jan; 61(1):221-4. PubMed ID: 264659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.